Peter A. Campochiaro, MD - Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care

Michelle C. Kaku, MD / Chafic Karam, MD - Targeted Therapy for Hereditary Transthyretin Amyloidosis Polyneuropathy (ATTRv-PN): You Don’t Want to Miss It!

Sandeep K. Gupta, MD, AGAF, FACG, FASGE, Jenifer R. Lightdale, MD, MPH - Fast Track to Relief: Accelerating Treatment Initiation and Supporting Patient Follow-Up in Pediatric Eosinophilic Esophagitis

Jared R. Brosch, MD - Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer’s Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management

Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC

Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC

M. Camille Hoffman, MD, MSc - From Screening Through Treatment: Proactive Engagement of Patients in Team-Based Care for PPD

Nitin Jain, MD - Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation

Kent E. Vrana, PhD, FAAAS, FASPET - Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making

Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities

Mohammad AZ Al-Ani, MD, FACC, FSCMR - Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical Center

Kathleen M. Buchheit, MD, Joseph K. Han, MD, FARS, FAAAAI - Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment

Paul Kwo, MD, AGAF, FACG, FAASLD - The Path to Viral Hepatitis Elimination: Enhancing Screening, Vaccination, Treatment, and Care

Jennifer Hsiao, MD - Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel Agents

Krish Patel, MD - Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment and Implications for Targeted Therapy and Other Innovative Options

Jessica Ailani, MD, FAHS, FAAN - From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies

Sarah Cuddy, MD / Ronald Witteles, MD - Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis

Margaret H. Collins, MD, AGAF, Nirmala Gonsalves, MD, AGAF, FACG - Beyond the Eosinophil: Mastering the Complexities of EoE Diagnosis

Jared R. Brosch, MD - Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer’s Disease: New Data and Clinical Pearls From AAIC 2025

Sami L. Khella, MD - Targeted Treatments for Transthyretin Amyloidosis: Essential Insights for Neurologists